T1	Participants 57 95	locally advanced nasopharyngeal cancer
T2	Participants 333 398	patients with locoregionally advanced nasopharyngeal cancer (NPC)
T3	Participants 421 510	From August 1999 to December 2004, 206 patients with locally advanced NPC were randomised
T4	Participants 1730 1762	locoregional advanced stage NPC.
